ClinicalTrials HQ

A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

Recruiting · NCT05463263 · Registry updated 2026-06-16
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell LymphomasB-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmRecruitingPhase 1 / Phase 22026-06-16NCT05463263

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Step Pharma, SAS3

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
CHU de NantesNantesFrance60
Churchill HospitalOxfordUnited Kingdom17
Colorado Blood Cancer InstituteDenverUnited States178
Derriford HospitalPlymouthUnited Kingdom27
Florida Cancer SpecialistsSarasotaUnited States47
Hôpital Saint-LouisParisFrance1
Imperial College / Clinical Trials Unit, Hammersmith HospitalLondonUnited Kingdom1
Institut Gustave RoussyVillejuifFrance58
Institut Paoli CalmettesMarseilleFrance49
Memorial Sloan KetteringNew YorkUnited States27
Nottingham City HospitalNottinghamUnited Kingdom19
The Centre Léon BérardLyonFrance1
The ChristieManchesterUnited Kingdom7
The Royal MarsdenSuttonUnited Kingdom2
University Hospitals of Leicester NHS TrustLeicesterUnited Kingdom19